UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

Journal of cancer research and clinical oncology, 2022-08, Vol.148 (8), p.2115-2125

2022

Volltextzugriff (PDF)

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

Journal of cancer research and clinical oncology, 2019-02, Vol.145 (2), p.479-485

2019

Volltextzugriff (PDF)

Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning

Journal of cancer research and clinical oncology, 2021-03, Vol.147 (3), p.821-833

2021

Volltextzugriff (PDF)

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

Journal of cancer research and clinical oncology, 2019-10, Vol.145 (10), p.2541-2546

2019

Volltextzugriff (PDF)

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Journal of cancer research and clinical oncology, 2018-05, Vol.144 (5), p.945-954

2018

Volltextzugriff (PDF)

Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer

Journal of cancer research and clinical oncology, 2019-12, Vol.145 (12), p.3105-3114

2019

Volltextzugriff (PDF)

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

Journal of cancer research and clinical oncology, 2020-04, Vol.146 (4), p.1065-1077

2020

Volltextzugriff (PDF)

GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients

Journal of cancer research and clinical oncology, 2022-10, Vol.148 (10), p.2643-2652

2022

Volltextzugriff (PDF)

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.1905-1915

2023

Volltextzugriff (PDF)

Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

Journal of cancer research and clinical oncology, 2019-02, Vol.145 (2), p.511-521

2019

Volltextzugriff (PDF)

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

Journal of cancer research and clinical oncology, 2019-06, Vol.145 (6), p.1613-1623

2019

Volltextzugriff (PDF)

Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients

Journal of cancer research and clinical oncology, 2021-12, Vol.147 (12), p.3725-3734

2021

Volltextzugriff (PDF)

Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters

Journal of cancer research and clinical oncology, 2021-12, Vol.147 (12), p.3757-3767

2021

Volltextzugriff (PDF)

Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials

Journal of cancer research and clinical oncology, 2021-08, Vol.147 (8), p.2407-2420

2021

Volltextzugriff (PDF)

Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)

Journal of cancer research and clinical oncology, 2022-01, Vol.148 (1), p.225-236

2022

Volltextzugriff (PDF)

C-reactive protein as an early marker of immune-related adverse events

Journal of cancer research and clinical oncology, 2019-10, Vol.145 (10), p.2625-2631

2019

Volltextzugriff (PDF)

Machine learning for optimized individual survival prediction in resectable upper gastrointestinal cancer

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.1691-1702

2023

Volltextzugriff (PDF)

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)

Journal of cancer research and clinical oncology, 2019-03, Vol.145 (3), p.725-736

2019

Volltextzugriff (PDF)

Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome

Journal of cancer research and clinical oncology, 2020-11, Vol.146 (11), p.3063-3074

2020

Volltextzugriff (PDF)

Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma

Journal of cancer research and clinical oncology, 2020-11, Vol.146 (11), p.3003-3012

2020

Volltextzugriff (PDF)

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3039-3046

2022

Volltextzugriff (PDF)

Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study

Journal of cancer research and clinical oncology, 2022-07, Vol.148 (7), p.1711-1720

2022

Volltextzugriff (PDF)

Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3183-3189

2022

Volltextzugriff (PDF)

Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment

Journal of cancer research and clinical oncology, 2022-05, Vol.148 (5), p.1123-1135

2022

Volltextzugriff (PDF)

The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy

Journal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3103-3108

2022

Volltextzugriff (PDF)

1 – 25 von 6.993

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.970)
Mit Volltextzugriff
(6.821)

Publikationsform

Artikel
(6.993)

Sprache

Englisch
(6.702)
Französisch
(290)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.491)
Life Sciences & Biomedicine
(6.487)
Oncology
(6.474)
Medicine
(6.033)
Medicine & Public Health
(6.026)
Humans
(4.792)
Original Article
(4.662)
Female
(3.210)
Male
(3.093)
Cancer Research
(2.921)
Middle Aged
(2.829)
Aged
(2.418)
Clinical Trials
(2.299)
Hematology
(2.155)
Adult
(2.146)
Patients
(2.044)
Internal Medicine
(1.829)
Cancer
(1.582)
Original
(1.425)
Chemotherapy
(1.395)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLink
(6.027)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(5.720)
MEDLINE
(4.873)
Ingenta
(4.169)
Journals@Ovid Full Text
(3.307)
EZB Electronic Journals Library
(1.426)
Nature
(701)
Nexis Uni
(689)
Publisher or Other Site
(492)
HEAL-Link subscriptions: Springer Book Series
(304)
IngentaConnect Journals
(207)
Wiley Blackwell Single Titles
(156)
Thieme Connect Journals
(77)
Cambridge Journals Online (DEFF)
(40)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(32)
SAGE Journals
(30)
Wiley Online Library
(23)
Psychology & Behavioral Sciences Collection
(14)
Access via Business Source (EBSCOhost)
(6)
PAIS Index
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board

Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients

Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters

Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials

Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)

C-reactive protein as an early marker of immune-related adverse events

Machine learning for optimized individual survival prediction in resectable upper gastrointestinal cancer

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)

Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome

Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case–control study

Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma

Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment

The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy

Suchergebnisse filtern